The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gill Ajit since 2005.
The trader's CIK number is 1236921.
At the time of the last reporting, Gill Ajit was the CEO of Nektar Therapeutics. (stock ticker symbol NKTR).
Also see all insider trading activities at Nektar Therapeutics.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | NKTR | 0 | $0 | 43,545 | $953,037 | 43,110 | $788,481 |
| 2005 | NKTR | 0 | $0 | 40,000 | $836,249 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-03-23 | NKTR | Sale | 3,545 | 19.61 | 69,517 |
| 2006-01-27 | NKTR | Sale | 40,000 | 22.09 | 883,520 |
| 2006-01-11 | NKTR | Option Ex | 43,110 | 18.29 | 788,481 |
| 2005-09-09 | NKTR | Sale | 30,000 | 21.17 | 635,100 |
| 2005-09-07 | NKTR | Sale | 10,000 | 20.11 | 201,149 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gill Ajit (CEO of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.